drugset
drugset / Trial / NCT04221126

TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence

NCT04221126 ↗

Phase 4 Completed 16 enrolled Merete Haedersdal
RandomizedParallel-groupOpen-labelTreatment

Summary

This study investigates a relatively new device TMFI and incubation of ALA in a cream-vehicle and a gel-vehicle.

Timeline

Start
2019-04-29
Primary completion
2019-08-08
Completion
2019-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent — Topical

Indications

No indication recorded.